Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

GHK-Cu Dosage for Skin Rejuvenation: Topical vs Systemic Comparison

The following table compares validated dosing protocols across topical and systemic administration routes documented in peer-reviewed research. Topical (cream/serum) 0.05–1% by weight Once or twice daily Improved skin laxity, fine line reduction, dermal densit

This source-based comparison does not add ratings or recommend a winner.

  • The following table compares validated dosing protocols across topical and systemic administration routes documented in peer-reviewed research.
  • Topical (cream/serum)
  • 0.05–1% by weight
  • Once or twice daily
  • Improved skin laxity, fine line reduction, dermal density increase (12-week timelines)
  • pH 5.5–7.0, refrigeration preferred, 30-day use window
  • Best for non-invasive research; requires penetration enhancers for efficacy
  • Topical (liposomal encapsulated)
  • 0.5–1% by weight
  • Once daily
  • Enhanced collagen I/III gene expression, measured via RT-PCR at 8 weeks
  • Liposome integrity maintained at 2–8°C, protect from light
  • Superior dermal delivery compared to standard formulations; higher cost per milligram
  • Subcutaneous injection
  • 0.5–2mg per injection site
  • 1–3 times per week
  • Accelerated wound closure, increased tensile strength in healing models
  • Sterile saline or bacteriostatic water, single-use vials, 2–8°C storage
  • Direct dermal access; suitable for localized tissue repair studies
  • Systemic (research only)
  • 1–5mg IV or IM
  • Protocol-dependent
  • Systemic anti-inflammatory markers, fibroblast proliferation in distant tissue
  • Aseptic preparation, immediate use post-reconstitution
  • Not validated for cosmetic endpoints; used in wound healing and tissue engineering
  • Topical protocols dominate cosmetic and dermatological research because they avoid systemic distribution and hepatic first-pass metabolism, delivering peptide directly to target tissue. Subcutaneous administration is reserved for wound healing models or localized scar remodeling studies where intact stratum corneum prevents adequate topical penetration.